Spine-Tech (SPYN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Spine-Tech (SPYN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: .com who wrote (37)	8/26/1996 12:41:00 AM
From: Bruce Payne	of 242

Scott--I wouldn't worry too much about the price just yet. This is still a story stock. If you are confident about FDA approval then the stock will rise. You probably have more info on this Co than Wall St. The stock got way ahead of itself this spring and is correcting. Also couple of bad news stories (1. analyst downgrade and 2. large international sales decline) are not helping. Also w/ the ramp up for domestic sales, have had neg earnings for last 12 mos. This will change w/approval and sales coming in. Has your Dr. given you an idea of the cost to him of BAK/L. I read an article published in Apr. that estimated a $226M market by 2000. I hope that is low :)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next